日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

肾移植受者从钙调神经磷酸酶抑制剂转换为贝拉西普治疗后的心血管风险:一项随机临床试验

Bredewold, Obbo W; Chan, Joe; Svensson, My; Bruchfeld, Annette; de Fijter, Johan W; Furuland, Hans; Grinyo, Josep M; Hartmann, Anders; Holdaas, Hallvard; Hellberg, Olof; Jardine, Alan; Mjörnstedt, Lars; Skov, Karin; Smerud, Knut T; Soveri, Inga; Sørensen, Søren S; Zonneveld, Anton-Jan van; Fellström, Bengt

Increased risk of ischaemic heart disease after kidney donation

肾脏捐献后患缺血性心脏病的风险增加

Haugen, Anders J; Hallan, Stein; Langberg, Nina E; Dahle, Dag Olav; Pihlstrøm, Hege; Birkeland, Kåre I; Reisæter, Anna V; Midtvedt, Karsten; Hartmann, Anders; Holdaas, Hallvard; Mjøen, Geir

Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial

血液透析患者血清纤维化标志物、心血管疾病和全因死亡率:AURORA试验

Salib, Madonna; Girerd, Sophie; Girerd, Nicolas; März, Winfried; Scharnagl, Hubert; Massy, Ziad A; Leroy, Céline; Duarte, Kévin; Holdaas, Hallvard; Jardine, Alan G; Schmieder, Roland E; Fellström, Bengt; López-Andrés, Natalia; Rossignol, Patrick; Zannad, Faiez

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

NT-proBNP 和干细胞因子血浆浓度与终末期肾病血液透析患者的心血管结局独立相关。

Rossignol, P; Duarte, K; Bresso, E; A, Åsberg; Devignes, M D; Eriksson, N; Girerd, N; Glerup, R; Jardine, A G; Holdaas, H; Lamiral, Z; Leroy, C; Massy, Z; März, W; Krämer, B; Wu, P H; Schmieder, R; Soveri, I; Christensen, J H; Svensson, M; Zannad, F; Fellström, B

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

利用机器学习模型和循环微核糖核酸提高终末期肾病血液透析患者的心血管风险预测能力

de Gonzalo-Calvo, David; Martínez-Camblor, Pablo; Bär, Christian; Duarte, Kevin; Girerd, Nicolas; Fellström, Bengt; Schmieder, Roland E; Jardine, Alan G; Massy, Ziad A; Holdaas, Hallvard; Rossignol, Patrick; Zannad, Faiez; Thum, Thomas

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial

AURORA试验表明,动静脉瘘血栓形成与血液透析患者的全因死亡率和心血管死亡率增加相关。

Girerd, Sophie; Girerd, Nicolas; Frimat, Luc; Holdaas, Hallvard; Jardine, Alan G; Schmieder, Roland E; Fellström, Bengt; Settembre, Nicla; Malikov, Sergei; Rossignol, Patrick; Zannad, Faiez

Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients

探索帕立骨化醇对肾移植受者炎症标志物的潜在影响

Hege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, Pål Aukrust, Franscesca Gatti, Clara Hammarström, Monika Kasprzycka, Junbai Wang, Guttorm Haraldsen, Geir Mjøen, Dag Olav Dahle, Karsten Midtvedt, Ivar Anders Eide, Anders Hartmann, Hallvard Holdaas

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection

估算白蛋白排泄率在慢性肾脏病预后中的作用:来自心脏和肾脏保护研究的结果

Mafham, Marion M; Staplin, Natalie; Emberson, Jonathan; Haynes, Richard; Herrington, William; Reith, Christina; Wanner, Christoph; Walker, Robert; Cass, Alan; Levin, Adeera; Fellström, Bengt; Jiang, Lixin; Holdaas, Hallvard; Kasiske, Bertram; Wheeler, David C; Landray, Martin J; Baigent, Colin

Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression

狼疮性肾炎:尿液中 DNase I 水平低反映肾脏 DNase I 的损失,可作为疾病进展的生物标志物

Hege L Pedersen, Kjersti D Horvei, Dhivya Thiyagarajan, Gudrun E Norby, Natalya Seredkina, Gabriella Moroni, Gro Ø Eilertsen, Hallvard Holdaas, Erik H Strøm, Gunnstein Bakland, Pier-Luigi Meroni, Ole P Rekvig

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

肾移植术后第一年补充帕立骨化醇不影响钙化倾向评分

Ussif, Amin; Pihlstrøm, Hege; Pasch, Andreas; Holdaas, Hallvard; Hartmann, Anders; Smerud, Knut; Åsberg, Anders